Intellia Therapeutics, Inc. (NTLA)

13.85 +0.54 (+4.06%) USD  |  NASDAQ  |  May 06, 16:00
13.83 -0.02 (-0.14%) Pre-Market: 08:25
More

Intellia Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Recursion Pharmaceuticals, Inc. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Novavax, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade